Editorial: Is BAFF the murderer in lupus?

1 D'Cruz DP  Khamashta MA  Hughes GR  . Systemic lupus erythematosus . Lancet 2007; 369: 587 – 596 .

2 Lipsky PE  . Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity . Nat Immunol 2001; 2: 764 – 766 .

3 Youinou P  Daridon C  Steinfeld S  Pers JO  . A case for B cells in the pathogenesis of Sjögren's syndrome . Trends Immunol (in press).

4 Martinez-Gamboa L  Brezinschek HP  Burmester GR  Dörner T  . Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy . Autoimmun Rev 2006; 5: 437 – 442 .

5 Mackay F  Silveira PA  Brink R  . B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling . Curr Opin Immunol 2007; 19: 327 – 336 .

6 Daridon C  Youinou P  Pers JO  . BAFF, APRIL, TWE-PRIL: Who's who . Autoimmun Rev 2008; 7: 267 – 271 .

7 Bossen C  Schneider P  . BAFF, APRIL and their receptors: structure, function and signaling . Semin Immunol 2006; 18: 263 – 275 .

8 Daridon C  Devauchelle V  Hutin P  . Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome . Arthritis Rheum 2007; 56: 1134 – 1144 .

9 Sutherland AP  Ng LG  Fletcher CA  . BAFF augments certain Th1-associated inflammatory responses . J Immunol 2005; 174: 5537 – 5544 .

10 Mackay F  Woodcock SA  Lawton P  . Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations . J Exp Med 1999; 190: 1697 – 1710 .

11 Groom J  Kalled SL  Cutler AH  . Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome . J Clin Invest 2002; 109: 59 – 68 .

12 Batten M  Groom J  Cachero TG  . BAFF mediates survival of peripheral immature B lymphocytes . J Exp Med 2000; 192: 1453 – 1466 .

13 Groom JR  Fletcher CA  Walters SN  . BAFF and MyD88 signals promote a lupus like disease independent of T cells . J Exp Med 2007; 204: 1959 – 1971 .

14 Zouali M  . Receptor editing and receptor revision in rheumatic autoimmune diseases . Trends Immunol 2008; 29: 103 – 109 .

15 Rochas C; Hillion S; Saraux A; . Transmembrane BAFF from rheumatoid synoviocytes requires IL-6 to induce the expression of RAGs in B lymphocytes (submitted for publication).

16 Pers JO  Daridon C  Devauchelle V  . BAFF overexpression is associated with autoantibody production in autoimmune diseases . Ann N Y Acad Sci 2005; 1050: 34 – 39 .

17 Pers JO  Devauchelle V  Daridon C  . BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome . Arthritis Rheum 2007; 56: 1464 – 1477 .

18 Zhang J  Roschke V  Baker KP  . Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus . J Immunol 2001; 166: 6 – 10 .

19 Stohl W  . Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders . Expert Opin Ther Targets 2004; 8: 177 – 189 .

20 Le Pottier L  Bendaoud B  Dueymes M  . BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer . J Clin Immunol 2007; 27: 257 – 265 .